Federal government pushing two million vaccines to provinces in coming days - National Post | Canada News Media
Connect with us

Business

Federal government pushing two million vaccines to provinces in coming days – National Post

Published

 on


Maj.-Gen. Dany Fortin said ‘despite the bumps,’ Canada’s vaccine effort is going well now with deliveries set to continue at large volumes into the spring

Article content

OTTAWA – Provinces will receive two million doses of desperately needed vaccines in the days ahead, as the federal government pushes out the last of 9.5 million doses Canada has received so far.

The Liberals’ first target for the rollout was six million doses by the end of the first quarter, which it then increased to 9.5 million earlier this month. Pfizer has met its total and on Thursday the government was shipping 1.5 million doses of AstraZeneca that arrived from the United States to provinces. Nearly 600,000 doses of Moderna’s vaccine that were originally set to arrive last week, were set to land in Canada on Friday morning and be sent to provinces over the weekend.

Maj.-Gen. Dany Fortin said Canada’s vaccine effort is going well now with deliveries set to continue at large volumes into the spring.

“Despite the bumps Canada has seen over the last three months, it’s important to note some great successes along the way,” he said. “By the end of this week, we can expect to have distributed approximately 9.5 million COVID-19 vaccine doses across the country.”

Advertisement

Story continues below

This advertisement has not loaded yet, but your article continues below.

Article content

Government officials speaking on background said the government was paying a premium to its shipping companies to get the newly arriving vaccines out quickly over the holiday weekend.

Announcing a one-month lockdown for his province that begins Saturday, Ontario Premier Doug Ford was less critical of the federal government’s rollout than he has been recently.

He said he was confident millions of doses would arrive in his province in the coming months and the province had to close down so the vaccines could catch up.

“We need more time for our vaccine program to take hold,” he said. “We need more runway to let our vaccination rollout get to where we need it.”


  1. AstraZeneca COVID shots could test Canadians’ vaccine hesitancy: ‘There is no way they can downplay that risk’


  2. Ontario imposes four-week provincewide ‘shutdown’ to combat spike in COVID-19 cases

Fortin announced 300,000 doses of the AstraZeneca vaccine would also be arriving next week, through the COVAX facility. COVAX is an international partnership that has developing countries purchase vaccines for both themselves and the developing world. Canada is one of a few developed nations to actually draw on the facility.

There are another 1.5 million doses of AstraZeneca coming from the Serum Institute, an Indian manufacturer. A million of those doses were set to arrive in mid-April, and another 500,000 in May.

Advertisement

Story continues below

This advertisement has not loaded yet, but your article continues below.

Article content

Joelle Paquette, a director general with Public Services and Procurement Canada said they were expecting a delay, but could not provide any more details on that shortage.

“We’re working with the company on determining when the doses will arrive. We are expecting a delay in the shipment, but they are committed to meeting their contractual obligations,” she said.

As COVID-19 resurges in India, the country’s government has been less willing to see doses leave the country.

Paquette said they were also working with Johnson and Johnson to determine a delivery schedule for its one-dose vaccine. Procurement minster Anita Anand said she earlier this week they expected the first shipments in late April, but the company suffered a manufacturing setback on Wednesday.

Paquette said they don’t believe that issue will impact Canada’s shipments, but she did not have a specific date for deliveries.

The AstraZeneca vaccine is now limited to people over the age of 55 due to new evidence the vaccine can cause potentially fatal blood clots in younger people.

Dr. Howard Njoo, Canada’s deputy chief public health officer said Canada has seen no incidents of the rare blood clots and is limiting the vaccines use purely as a precaution due to evidence in Europe.

He said he understands why Canadians in the approved age group could be hesitant to take the vaccine, but he encouraged people to see it as the system working.

Advertisement

Story continues below

This advertisement has not loaded yet, but your article continues below.

Article content

“I encourage you to recognize this latest adjustment to guidance in the vaccine administration, what it is an outcome of our robust safety monitoring system and ongoing global collaboration,” he said.

Njoo said the vaccine is safe and effective and prevents hospitalizations and deaths. He said any Canadian offered it should take it.

“I have no hesitation in saying that, if the vaccine was offered to me tomorrow I would take it. Certainly this vaccine along with the other three approved vaccines have all been shown to be very effective in preventing serious illness and death.”

• Email: rtumilty@postmedia.com | Twitter:

Advertisement

Story continues below

This advertisement has not loaded yet, but your article continues below.

Comments

Postmedia is committed to maintaining a lively but civil forum for discussion and encourage all readers to share their views on our articles. Comments may take up to an hour for moderation before appearing on the site. We ask you to keep your comments relevant and respectful. We have enabled email notifications—you will now receive an email if you receive a reply to your comment, there is an update to a comment thread you follow or if a user you follow comments. Visit our Community Guidelines for more information and details on how to adjust your email settings.

Let’s block ads! (Why?)



Source link

Continue Reading

Business

Japan’s SoftBank returns to profit after gains at Vision Fund and other investments

Published

 on

 

TOKYO (AP) — Japanese technology group SoftBank swung back to profitability in the July-September quarter, boosted by positive results in its Vision Fund investments.

Tokyo-based SoftBank Group Corp. reported Tuesday a fiscal second quarter profit of nearly 1.18 trillion yen ($7.7 billion), compared with a 931 billion yen loss in the year-earlier period.

Quarterly sales edged up about 6% to nearly 1.77 trillion yen ($11.5 billion).

SoftBank credited income from royalties and licensing related to its holdings in Arm, a computer chip-designing company, whose business spans smartphones, data centers, networking equipment, automotive, consumer electronic devices, and AI applications.

The results were also helped by the absence of losses related to SoftBank’s investment in office-space sharing venture WeWork, which hit the previous fiscal year.

WeWork, which filed for Chapter 11 bankruptcy protection in 2023, emerged from Chapter 11 in June.

SoftBank has benefitted in recent months from rising share prices in some investment, such as U.S.-based e-commerce company Coupang, Chinese mobility provider DiDi Global and Bytedance, the Chinese developer of TikTok.

SoftBank’s financial results tend to swing wildly, partly because of its sprawling investment portfolio that includes search engine Yahoo, Chinese retailer Alibaba, and artificial intelligence company Nvidia.

SoftBank makes investments in a variety of companies that it groups together in a series of Vision Funds.

The company’s founder, Masayoshi Son, is a pioneer in technology investment in Japan. SoftBank Group does not give earnings forecasts.

___

Yuri Kageyama is on X:

The Canadian Press. All rights reserved.

Source link

Continue Reading

Business

Trump campaign promises unlikely to harm entrepreneurship: Shopify CFO

Published

 on

 

Shopify Inc. executives brushed off concerns that incoming U.S. President Donald Trump will be a major detriment to many of the company’s merchants.

“There’s nothing in what we’ve heard from Trump, nor would there have been anything from (Democratic candidate) Kamala (Harris), which we think impacts the overall state of new business formation and entrepreneurship,” Shopify’s chief financial officer Jeff Hoffmeister told analysts on a call Tuesday.

“We still feel really good about all the merchants out there, all the entrepreneurs that want to start new businesses and that’s obviously not going to change with the administration.”

Hoffmeister’s comments come a week after Trump, a Republican businessman, trounced Harris in an election that will soon return him to the Oval Office.

On the campaign trail, he threatened to impose tariffs of 60 per cent on imports from China and roughly 10 per cent to 20 per cent on goods from all other countries.

If the president-elect makes good on the promise, many worry the cost of operating will soar for companies, including customers of Shopify, which sells e-commerce software to small businesses but also brands as big as Kylie Cosmetics and Victoria’s Secret.

These merchants may feel they have no choice but to pass on the increases to customers, perhaps sparking more inflation.

If Trump’s tariffs do come to fruition, Shopify’s president Harley Finkelstein pointed out China is “not a huge area” for Shopify.

However, “we can’t anticipate what every presidential administration is going to do,” he cautioned.

He likened the uncertainty facing the business community to the COVID-19 pandemic where Shopify had to help companies migrate online.

“Our job is no matter what comes the way of our merchants, we provide them with tools and service and support for them to navigate it really well,” he said.

Finkelstein was questioned about the forthcoming U.S. leadership change on a call meant to delve into Shopify’s latest earnings, which sent shares soaring 27 per cent to $158.63 shortly after Tuesday’s market open.

The Ottawa-based company, which keeps its books in U.S. dollars, reported US$828 million in net income for its third quarter, up from US$718 million in the same quarter last year, as its revenue rose 26 per cent.

Revenue for the period ended Sept. 30 totalled US$2.16 billion, up from US$1.71 billion a year earlier.

Subscription solutions revenue reached US$610 million, up from US$486 million in the same quarter last year.

Merchant solutions revenue amounted to US$1.55 billion, up from US$1.23 billion.

Shopify’s net income excluding the impact of equity investments totalled US$344 million for the quarter, up from US$173 million in the same quarter last year.

Daniel Chan, a TD Cowen analyst, said the results show Shopify has a leadership position in the e-commerce world and “a continued ability to gain market share.”

In its outlook for its fourth quarter of 2024, the company said it expects revenue to grow at a mid-to-high-twenties percentage rate on a year-over-year basis.

“Q4 guidance suggests Shopify will finish the year strong, with better-than-expected revenue growth and operating margin,” Chan pointed out in a note to investors.

This report by The Canadian Press was first published Nov. 12, 2024.

Companies in this story: (TSX:SHOP)

The Canadian Press. All rights reserved.

Source link

Continue Reading

Business

RioCan cuts nearly 10 per cent staff in efficiency push as condo market slows

Published

 on

 

TORONTO – RioCan Real Estate Investment Trust says it has cut almost 10 per cent of its staff as it deals with a slowdown in the condo market and overall pushes for greater efficiency.

The company says the cuts, which amount to around 60 employees based on its last annual filing, will mean about $9 million in restructuring charges and should translate to about $8 million in annualized cash savings.

The job cuts come as RioCan and others scale back condo development plans as the market softens, but chief executive Jonathan Gitlin says the reductions were from a companywide efficiency effort.

RioCan says it doesn’t plan to start any new construction of mixed-use properties this year and well into 2025 as it adjusts to the shifting market demand.

The company reported a net income of $96.9 million in the third quarter, up from a loss of $73.5 million last year, as it saw a $159 million boost from a favourable change in the fair value of investment properties.

RioCan reported what it says is a record-breaking 97.8 per cent occupancy rate in the quarter including retail committed occupancy of 98.6 per cent.

This report by The Canadian Press was first published Nov. 12, 2024.

Companies in this story: (TSX:REI.UN)

The Canadian Press. All rights reserved.

Source link

Continue Reading

Trending

Exit mobile version